Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, María Stamelou, Carolin Kurz et al.|Movement Disorders|2017Cited by 2.3k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Cliff R Jack, Harald Hampel et al.|Alzheimer s & Dementia|2016Cited by 1.9k
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s diseaseRik Ossenkoppele, Gil D. Rabinovici|Brain|2016Cited by 1.2k
Prevalence of Amyloid PET Positivity in Dementia SyndromesRik Ossenkoppele, Gaël Chételat, David J. Brooks et al.|JAMA|2015Cited by 668
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Charlotte E. Teunissen, Rebecca M. Edelmayer et al.|Alzheimer s & Dementia|2022Cited by 589